AnalystsColleen KusyColleen Kusy's Stock Forecasts
AnalystsColleen Kusy
Sectors:
Industries:
Analyst Ranking
Top 35%
#1490 out of 4241 analysts
Average Return
+3.04%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Colleen Kusy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Iveric Bio IncISEE | +150.13% | $14.94 | $37.37 | 2022-09-07 - 2023-05-04 | Buy |
Apellis Pharmaceuticals IncAPLS | +53.86% | $58.50 | $90.01 | 2023-02-21 - 2023-06-09 | Buy |
Iveric Bio IncISEE | +52.71% | $15.50 | $23.67 | 2022-03-03 - 2023-03-02 | Buy |
Mersana Therapeutics IncMRSN | +22.14% | $7.00 | $8.55 | 2022-08-09 - 2023-06-09 | Buy |
Ocular Therapeutix IncOCUL | +15.55% | $6.43 | $7.43 | 2023-04-21 - 2023-06-09 | Buy |
Colleen Kusy Analyst Color
Get additional color on Colleen Kusy's coverage of popular stocks
Colleen Kusy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oculis Holding AgOCS | 1 | Buy | $58.00 | +423.94% | Initiates Coverage On | 3 days ago |
Agenus IncAGEN | 1 | Buy | $8.00 | +302.01% | Initiates Coverage On | 5 days ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | +4.93% | Downgrades | a month ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $18.00 | +142.26% | Initiates Coverage On | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 1 | Buy | $105.00 | +16.65% | Maintains | 4 months ago |
Harpoon Therapeutics IncHARP | 1 | Hold | N/A | N/A | Downgrades | 7 months ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | 0.00% | Downgrades | 8 months ago |
Mersana Therapeutics IncMRSN | 1 | Buy | $20.00 | +133.92% | Maintains | 10 months ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $14.00 | +533.48% | Maintains | 10 months ago |
Iovance Biotherapeutics IncIOVA | 2 | Buy | $34.00 | N/A | Maintains | a year ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.